Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials.
暂无分享,去创建一个
[1] T. Taguchi,et al. [Phase I study]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.
[2] B E Storer,et al. Design and analysis of phase I clinical trials. , 1989, Biometrics.
[3] E. Eisenhauer,et al. Phase I trial design: are new methodologies being put into practice? , 1996, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] L. Edler. Statistical requirements of phase I studies. , 1990, Onkologie.
[5] J Whitehead,et al. Bayesian decision procedures for dose determining experiments. , 1995, Statistics in medicine.
[6] S Zacks,et al. Cancer phase I clinical trials: efficient dose escalation with overdose control. , 1998, Statistics in medicine.
[7] B. Carlin,et al. Adaptive design improvements in the continual reassessment method for phase I studies. , 1999, Statistics in medicine.
[8] L V Rubinstein,et al. A comparison of two phase I trial designs. , 1994, Statistics in medicine.
[9] J. Lee,et al. Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.